Document is current

Any future updates will be listed below

Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s40001-024-02241-4

Published Online: 2025-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark